Resonant Capital Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Sell
855
-118
-12% -$49.9K 0.02% 395
2026
Q1
$460K Buy
973
+92
+10% +$46.3K 0.02% 282
2025
Q4
$411K Buy
881
+106
+14% +$49.2K 0.02% 283
2025
Q3
$330K Sell
775
-253
-25% -$98.1K 0.02% 311
2025
Q2
$394K Buy
1,028
+191
+23% +$68.8K 0.03% 275
2025
Q1
$289K Buy
+837
New +$269K 0.02% 295
2024
Q4
Sell
-493
Closed -$200K 357
2024
Q3
$200K Buy
+493
New +$180K 0.01% 349

Other funds holding HCA

Resonant Capital Advisors's HCA Position: Q2 2026 in Review

Resonant Capital Advisors reduced its HCA Healthcare (HCA) stake by 12% in Q2 2026, selling an estimated $49.9K and leaving 855 shares worth $333K. The position accounts for 0.02% of the portfolio, ranked #395.

Resonant Capital Advisors first reported a position in HCA in Q3 2024 and has held it in 7 quarters since. The position peaked at $460K in Q1 2026. 682 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Resonant Capital Advisors held 855 shares of HCA Healthcare worth $333K as of Q2 2026.
  • Resonant Capital Advisors sold 118 HCA Healthcare shares in Q2 2026, an estimated $49.9K.
  • HCA Healthcare made up 0.02% of Resonant Capital Advisors's portfolio in Q2 2026, its #395 holding.
  • Resonant Capital Advisors first reported a position in HCA Healthcare in Q3 2024 and has held it in 7 quarters since.
  • Resonant Capital Advisors's HCA Healthcare position peaked at $460K in Q1 2026.
  • 682 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.